Faster shipping and a ‘buy button’ are the latest innovations in the fight to entice buyers.
Women held at a maximum security facility were preyed on by correctional staff, investigators found.
The sports giant risks losing the loyalty of soccer fans it has spent years developing.
Few of leading GOP contenders have expressed interest this year, and several are skipping event entirely.
A roundup of national business and economic news.
Activities are already common in some schools, but not systemwide.
After months of hinting at an about-face, Christie is officially forswearing the Common Core academic standards he welcomed into the state five years ago.
The diverse early nominating state is a testing ground for his self-portrait as a new kind of Republican.
The Salton Sea in the Sonoran Desert needs more water. So does about every other place in the state.
Paper tests for more than 260 students at a Loudoun County high school were lost in transit.
The former speaker was indicted by federal prosecutors on Thursday.
Stalled USPS contract talks will not affect service. Federal labor leaders have little to say about OPM directive prohibiting use of weed by feds.
The former New York governor aims to position himself as a relative centrist in a right-leaning race.
A hazardous materials teams at Osan Air Base in South Korea destroyed a sample found there Wednesday, defense officials said.
Thousands of troops who were charged excess interest on their student loans by Navient Solutions will start getting checks in the mail next month for up to $100,000.
New federal report highlights chronic-disease risks and daily life struggles for people with serious mental health problems.
Floyd Dent testified that he feared for his life. Former officer William Melendez will stand trial on assault charges.
What happens next in the fight over the death penalty in Nebraska — and what happens to the state's 10 death row inmates.
N.J. governor joins other GOP presidential hopefuls in a revolt against the academic standards.
Even as they celebrate previously unimaginable progress, experts warn the drugs don’t work for all.